110 related articles for article (PubMed ID: 17846228)
1. The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
Despouy G; Joiner M; Le Toriellec E; Weil R; Stern MH
Blood; 2007 Dec; 110(13):4406-16. PubMed ID: 17846228
[TBL] [Abstract][Full Text] [Related]
2. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
[TBL] [Abstract][Full Text] [Related]
3. T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation.
Hoyer KK; Herling M; Bagrintseva K; Dawson DW; French SW; Renard M; Weinger JG; Jones D; Teitell MA
J Immunol; 2005 Jul; 175(2):864-73. PubMed ID: 16002684
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase mediates T cell activation-induced expression of FasL and COX-2 via protein kinase C theta-dependent pathway in human Jurkat T leukemia cells.
Lee JY; Choi AY; Oh YT; Choe W; Yeo EJ; Ha J; Kang I
Cell Signal; 2012 Jun; 24(6):1195-207. PubMed ID: 22330070
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family.
Laine J; Künstle G; Obata T; Noguchi M
J Biol Chem; 2002 Feb; 277(5):3743-51. PubMed ID: 11707444
[TBL] [Abstract][Full Text] [Related]
6. The protooncogene TCL1 is an Akt kinase coactivator.
Laine J; Künstle G; Obata T; Sha M; Noguchi M
Mol Cell; 2000 Aug; 6(2):395-407. PubMed ID: 10983986
[TBL] [Abstract][Full Text] [Related]
7. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.
Roose JP; Mollenauer M; Gupta VA; Stone J; Weiss A
Mol Cell Biol; 2005 Jun; 25(11):4426-41. PubMed ID: 15899849
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
9. Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death.
Kaminski M; Kiessling M; Süss D; Krammer PH; Gülow K
Mol Cell Biol; 2007 May; 27(10):3625-39. PubMed ID: 17339328
[TBL] [Abstract][Full Text] [Related]
10. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.
Künstle G; Laine J; Pierron G; Kagami Si S; Nakajima H; Hoh F; Roumestand C; Stern MH; Noguchi M
Mol Cell Biol; 2002 Mar; 22(5):1513-25. PubMed ID: 11839817
[TBL] [Abstract][Full Text] [Related]
11. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
Chiali-Gritti C
Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
Auguin D; Barthe P; Royer C; Stern MH; Noguchi M; Arold ST; Roumestand C
J Biol Chem; 2004 Aug; 279(34):35890-902. PubMed ID: 15169787
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.
Chwae YJ; Chang MJ; Park SM; Yoon H; Park HJ; Kim SJ; Kim J
J Immunol; 2002 Oct; 169(7):3726-35. PubMed ID: 12244166
[TBL] [Abstract][Full Text] [Related]
14. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C.
Villalba M; Bi K; Hu J; Altman Y; Bushway P; Reits E; Neefjes J; Baier G; Abraham RT; Altman A
J Cell Biol; 2002 Apr; 157(2):253-63. PubMed ID: 11956228
[TBL] [Abstract][Full Text] [Related]
15. Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa and phospholipase C gamma 1 are required for NF-kappa B activation and lipid raft recruitment of protein kinase C theta induced by T cell costimulation.
Dienz O; Möller A; Strecker A; Stephan N; Krammer PH; Dröge W; Schmitz ML
J Immunol; 2003 Jan; 170(1):365-72. PubMed ID: 12496421
[TBL] [Abstract][Full Text] [Related]
16. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
[TBL] [Abstract][Full Text] [Related]
17. Filamin A is required for T cell activation mediated by protein kinase C-theta.
Hayashi K; Altman A
J Immunol; 2006 Aug; 177(3):1721-8. PubMed ID: 16849481
[TBL] [Abstract][Full Text] [Related]
18. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane.
French SW; Shen RR; Koh PJ; Malone CS; Mallick P; Teitell MA
Biochemistry; 2002 May; 41(20):6376-82. PubMed ID: 12009899
[TBL] [Abstract][Full Text] [Related]
19. A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.
Villalba M; Coudronniere N; Deckert M; Teixeiro E; Mas P; Altman A
Immunity; 2000 Feb; 12(2):151-60. PubMed ID: 10714681
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemias.
Villalba M; Altman A
Curr Cancer Drug Targets; 2002 Jun; 2(2):125-37. PubMed ID: 12188914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
